All > Massachusetts Investigators

Terrence C Hack, MD

Primary Care Cardiology Research, Inc

Ayer, Massachusetts - 01432 (978-772-5033)

Primary Care Cardiology Research

Ayer, Massachusetts - 01432-1124

CLINICAL TRIALS 2
CONDITIONS1
INTERVENTIONS2
SINCE2008

Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure

January 2010 - September 2010

OVATIO CRT and SITUS OTW LV Lead Post Approval Study

December 2008 -

Heart Failure

Placebo

Lixivaptan

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Terrence C Hack, MD

Primary Care Cardiology Research, Inc

Primary Care Cardiology Research

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP